Black Diamond Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BDTX and other ETFs, options, and stocks.

About BDTX

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases.

CEO

Mark A. Velleca

CEOMark A. Velleca

Employees

Employees24

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2014

Founded2014

Employees

Employees24

BDTX Key Statistics

Market cap

190.73M

Market cap190.73M

Price-Earnings ratio

13.34

Price-Earnings ratio13.34

Dividend yield

—

Dividend yield—

Average volume

970.33K

Average volume970.33K

High today

$3.35

High today$3.35

Low today

$3.16

Low today$3.16

Open price

$3.23

Open price$3.23

Volume

691.21K

Volume691.21K

52 Week high

$5.69

52 Week high$5.69

52 Week low

$1.20

52 Week low$1.20

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own BDTX. This list is generated using Robinhood data, and it’s not a recommendation.